Michael Baumann
Cancer Research · 2005–2017
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 17 citations into it
Whom Michael Baumann trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Michael Baumann overall
Papers from Michael Baumann's perspective
Ordered by how strongly the researchers Michael Baumann trusts endorse each paper. Same corpus, a different order for every researcher.
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (Nature)
- Hypoxia in cancer: significance and impact on clinical outcome (Cancer Metastasis Review)
- Making a tumour's bed: glioblastoma stem cells and the vascular niche (Nature Reviews. Cancer)
- HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. (Genes & Development)
- Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. (New England Journal of Medicine)
- Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. (Radiotherapy and Oncology)
- Stem Cells and Their Niches (Science)
- Cancerous stem cells can arise from pediatric brain tumors (Proceedings of the National Academy of Sciences of the United States of America)
- Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation (Molecular and Cellular Biology)
- Prospective identification of tumorigenic prostate cancer stem cells. (Cancer Research)
Their papers
- The PD‐1/PD‐L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG) (2017)
- HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2016)
- Radiation oncology in the era of precision medicine (2016) — 768 citations
- Expanding global access to radiotherapy. (2015) — 957 citations
- Exploring the role of cancer stem cells in radioresistance (2008) — 834 citations
- Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German (2005)